AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trialView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Achieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Sustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in KenyaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020High seroprevalence of viral hepatitis among animal handlers in Abeokuta, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Seroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Seroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Viral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence studyView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Comparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Short Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma in an HBx transgenic mouse modelView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Global elimination of hepatitis C: meeting the World Health Organization’s 2030 goalView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Gilead Sciences’ Commitment to Global Elimination of Hepatitis C VirusView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Contact tracing to engage hard to reach injection networks and achieve micro-elimination: description of the ‘source patient indentification and group overlap treatment’ (spigot) pilot programView Abstract
